i think because of things like gene therapy, there is big tailwinds for companies like danaher.gement that has proven it can navigate all kinds of different environments. >> those are your three buys here's one you're saying to bailing on, apple. you say it would be so why not >> make a little controversial here it was training in this tight channel up until about the beginning of may, so it broke below it during the recovery, it ticked almost to the dollar below that old channel and moving lower again. i think from a technical perspective, it looks to be weakening. i think it's valuation, fundamental driven it was never really that expensive, and even if earnings expectations don't come down at all. you're talking 23 times in the out years, 2024, for example i do think the slowing consumers has to create some headwinds i think you saw some slack in the labor report today we know what's going on with credit card debt, and you're starting to see some warnings with hardware sales. not completely apples to apple, but iphone is still 50% of appear 8 sales even if it retraces 50% of

i production, some of the things the initiative looks to kind of meet, at least initially so tmo, danaherp of kind of stocks, i thought probably would be the once investors would look to first, maybe secondarilyyily pha and biotech. >> just wondering, if they're manufacturing or their facilities are overseas, this could be inflationary for them, so it costs them ultimately. >> right i think what the administration is trying to do is trying to bring some of the business back to the u.s the majority is based here f pharma has a big presence internationally, but i think he's trying to bring jobs back, obviously, and just trying to meet some of the demand that's here there's a lot of personnel that probably can benefit from more of the work being done in the u.s. we'll see, but it's very unclear right now, from the plan we have seen, whether this will be a one-time tax grand, or the money, how it's been earmarked is not very clear as of yet. >> big picture, a big week last week for regeneron in their ilea drug, and the cash flour generation coming out of the sector and the balance sheets acro

let's be murky and set expectations low >> we have a market flash on danaher, they set up plans for applied solutions into a separate publicly traded company. the company giving better than expected revenue guidance for the current quarter. jeff, you liked this one >> this is a stock we liked a lot. a less speculative play on biotech. sales are recurring revenue. something we hope for, we like to see that move it's their environmental business it's sort of a side from what their core business is i think investors like the focus. i think this is one you can stick with for a while >>> a lot more "fast money" to come up next -- >> powell probability. one week to the next fed meeting and it's anyone's guess how much they'll raise. our next guest says only one option the details next plus advertise advantage shares of netflix giving a boost on some new additions to the platform will it bring a split game surge or be a bridgerton bust? you're watching "fast money" live from times square (man 1) oh, it looks like we're in a screen saver. (man 2) but we need to go higher. (man 1) higher. (man 1) we

you have to look toward them >> i know you're watching danah er today, up 2% this morning as they announcenvironmental side of their business >> it was up 12, only up 5, makes no sense to me, but we need more clarity on the deal, and i think that's the issue david, i want to bring you just on this idea that there -- we have a dichotomy going on. we have an industrial economy that people are giving up rather rapidly because of the fed then we have so many other companies that are doing quite well that we can't necessarily, let's say, pin the tail of the fed on them. you're out there you talk to companies that, frankly, i think, are just doing quite well would you give us a sense of who you're seeing that is not worried about the near term future >> who is not worried about the near term future >> i'm thinking, like, warner brothers-discovery >> you know what you're going to have to wait until tomorrow but i will give you a little preview bob from paramount was very adamant that people are too negative too negative about the ad market, too negative in general about recession and the economy.